Feeds
189793 items (189793 unread) in 47 feeds
World Health Organization
(226 unread)
-
WHO news (100 unread)
-
Media
(146891 unread)
-
Reuters Health eLine
(2178 unread)
-
CNN Health (2233 unread)
-
NYT > Health (4529 unread)
-
NPR Health and Science (2963 unread)
-
ABC News: Health (6880 unread)
-
CBSnews.com: Health News (7951 unread)
-
BBC Health News (3350 unread)
-
CBC Health and Science News (2744 unread)
-
Australia ABC News: Health
(4827 unread)
-
China Xinghua Health News
(30 unread)
-
New York Times: Health
(6915 unread)
-
USATODAY.com Health - Top Stories (4435 unread)
-
The Seattle Times: Health (5878 unread)
-
International Herald Tribune: Health and Science (6871 unread)
-
HeraldToday.com: Health
-
WebMD Health Headlines
(5193 unread)
-
MedicineNet Daily News (9287 unread)
-
Medical News Today
(39471 unread)
-
iVillage Health
(5439 unread)
-
Topix.net - Health (5497 unread)
-
Newsvine - health
(20220 unread)
Bird Flu
(3072 unread)
-
MSNBC.com: Bird Flu (14 unread)
-
-
Medical News Today - Bird Flu/Avian Flu
(110 unread)
-
Diabetes
(8450 unread)
-
-
Medical News Today - Diabetes
(2206 unread)
-
Cholesterol
(3575 unread)
-
Topix.net - Cholesterol
(2031 unread)
-
Medical News Today - Cholesterol
(373 unread)
-
Cancer
(15146 unread)
-
-
-
Medical News Today - Breast Cancer News
(1731 unread)
-
Medical News Today - Cancer/Oncology News
(5816 unread)
-
HIV
(7272 unread)
-
-
Medical News Today - HIV/AIDS News
(1910 unread)
-
Women
(3823 unread)
-
-
Medical News Today - OBGYN News
(2595 unread)
-
Men
(1338 unread)
-
-
Medical News Today - Men's health News
(630 unread)
-
Medical News Today - HIV/AIDS News (84 unread)
-
International Support Needed To Help Haiti Rebuild Its AIDS Response
Posted: February 27th, 2010, 12:00am CST
UNAIDS calls for a coordinated approach in supporting Haiti, the country most affected by HIV in the Caribbean, to rebuild its AIDS response in the wake of the 12 January earthquake. Following an initial rapid assessment of the situation with the Ministry of Public Health and Population, UNAIDS has released the concept note Helping Haiti rebuild its AIDS response... -
Gene-Based Stem Cell Therapy Specifically Removes Cell Receptor That Attracts HIV
Posted: February 26th, 2010, 7:00am CST
UCLA AIDS Institute researchers successfully removed CCR5 - a cell receptor to which HIV-1 binds for infection but which the human body does not need - from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV... -
Survival Significantly Improved By Combined Drug Therapy To Treat TB And HIV
Posted: February 26th, 2010, 6:00am CST
Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosis... -
Stem Cell Therapy Removes Cell Receptor That Attracts HIV
Posted: February 26th, 2010, 5:00am CST
UCLA AIDS Institute researchers successfully removed CCR5 a cell receptor to which HIV-1 binds for infection but which the human body does not need from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV... -
News From The Journals Of The American Society For Microbiology
Posted: February 26th, 2010, 3:00am CST
Campylobacter Bacteria in Cattle Manure May Survive Composting Contrary to popular belief, some disease causing bacteria may actually survive the composting process... -
Sidibe, Goosby Meet With Leaders In Nigeria To Promote Country's Fight Against HIV/AIDS
Posted: February 25th, 2010, 7:00am CST
During a joint visit to Nigeria this week, UNAIDS Executive Director Michel Sidibe and Ambassador Eric Goosby, U.S. global AIDS coordinator, encouraged the country to ramp up its efforts to fight HIV/AIDS, Pana/Afrique en ligne reports... -
WHO AFRO Delegation Travels To U.S. To Discuss Health Care Collaboration
Posted: February 25th, 2010, 7:00am CST
Luis Gomes Sambo, the WHO's regional director for Africa, "is in the U.S. this week" for meetings with senior health officials and development agency representatives to discuss collaborating on health, the New Times/allAfrica.com reports. During his trip, Sambo will meet with Mirta Roses, the director of PAHO, in addition to other PAHO officials... -
Opinion: Test-And-Treat HIV Prevention; Canadian, G8 Africa Aid
Posted: February 25th, 2010, 7:00am CST
Test-And-Treat Model For Tackling HIV Not 'Common Sense' In a Guardian opinion piece, columnist Elizabeth Pisani challenges the assumptions made by the "mathematical model that shows that if we test everyone in Africa for HIV once a year and give everyone who tests positive expensive drugs right away and for the rest of their lives, we'll wipe out new HIV infections within seven years. ... -
HIV Drug Given To Protect A Fetus Should Be Avoided For One Year After Childbirth
Posted: February 25th, 2010, 6:00am CST
Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham (UAB)... -
Research Examines Use Of Antiretroviral Pills, Gels For Possible 'Pre-Exposure Prophylaxis' For HIV
Posted: February 24th, 2010, 7:00am CST
Several studies are examining whether periodic use of antiretroviral drugs in various forms -- including pills and vaginal or rectal gels -- can prevent HIV transmission during high-risk sexual encounters, according to researchers at the annual Conference on Retroviruses and Opportunistic Infections, the Washington Post reports... -
PointCare Donates Diagnostic Tests To Haitian Clinics To Ensure Resumption Of Critical HIV/AIDS Patient Care And Bolster Emergency Medical Treatment
Posted: February 24th, 2010, 6:00am CST
PointCare Technologies, pioneer inventor of a portable diagnostic system that enables effective HIV/AIDS monitoring for millions of people in remote areas of developing countries, has donated 4,000 (a month's supply) of its rapid PointCare NOW tests to Haitian clinics to ensure the resumption of critical care to HIV/AIDS patients... -
FDA Announces Possible Safety Concern For HIV Drug Combination
Posted: February 24th, 2010, 5:00am CST
The U.S. Food and Drug Administration announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart. When used together, the drugs may cause prolongation of the QT and PR intervals on an electrocardiogram... -
Cardin Opinion Piece Calls For Passage Of International Violence Against Women Act
Posted: February 23rd, 2010, 6:00am CST
Violence against women is a "global epidemic" that "devastates the lives of millions of women and girls" and "knows no national or cultural barriers," Sen. Benjamin Cardin (D-Md.) -- chair of the Helsinki Commission -- writes in a Baltimore Sun opinion piece supporting passage of the International Violence Against Women Act (S 2982)... -
News Outlets Examine ART, Microbicide Development Research Presented At Conference
Posted: February 23rd, 2010, 6:00am CST
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco. "Studies are underway testing whether periodic use of the drugs, either as pills or as vaginal or rectal gels, can prevent transmission of HIV in high-risk sexual encounters... -
AAAS Meeting Examines Test-And-Treat Model's Potential For Fighting HIV Spread, TB Co-Infection
Posted: February 23rd, 2010, 6:00am CST
Researchers speaking at the American Association for the Advancement of Science (AAAS) meeting on Saturday, discussed how a strategy to promote universal voluntary HIV tests and early antiretroviral treatment for patients living in high-risk areas might "derail the spread of [HIV/]AIDS, a battle where a successful vaccine remains elusive," the Associated Press/Washington Post reports... -
ViiV Healthcare Presents New Data From HIV/AIDS Portfolio Demonstrating Research Advances And Commitment To Patient Care At Conference On Retroviruses
Posted: February 23rd, 2010, 3:00am CST
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS... -
The 2010 Distinguished Scientist Award Goes To John Greenspan
Posted: February 22nd, 2010, 5:00am CST
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010. Greenspan is professor of oral pathology of the School of Dentistry at UCSF... -
News Outlets Examine HIV Vaccine Research, Cervical Cancer Screening Data Presented At Conference
Posted: February 22nd, 2010, 4:00am CST
Several news outlets examine the latest reports out of this week's Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. Researchers from the Maryland-based VIRxSYS Corporation on Thursday presented data on the outcomes of the company's HIV vaccine, VRX1023, from a recent trial carried out in monkeys, Reuters reports... -
Recent Releases In Global Health
Posted: February 22nd, 2010, 4:00am CST
Blog: Goosby Reflects On U.S. Response To Global HIV/AIDS At CROI The Infectious Diseases Center for Global Health Policy's "Science Speaks" blog examines U.S... -
Halt HIV Spread In 5 Years With Test And Treat Plan Says Expert
Posted: February 22nd, 2010, 4:00am CST
While the search for a vaccine is important, by testing and immediately treating people in high risk areas with antiretrovirals we could stop HIV spreading in five years and eradicate HIV/AIDS altogether in 40 years, says an expert who spoke at a conference at the weekend... -
UNAIDS Welcomes South Africa's New US$ 1.1 Billion Investment On AIDS For 2010
Posted: February 21st, 2010, 3:00am CST
UNAIDS welcomes the increased investments by South Africa to the AIDS response. In his 2010 budget speech, Finance Minister Pravin Gordhan has proposed an allocation of US$ 1.1 billion, a 33% increase from 2009 levels. This is the biggest domestic investment made by any developing country on AIDS to date... -
Extending Tuberculosis Preventive Treatment Could Dramatically Reduce Illness Among HIV-Positive Individuals In Many Areas Of The World
Posted: February 21st, 2010, 2:00am CST
A simple change in the drug regimen used to prevent active tuberculosis disease among HIV-positive people who test positive for latent TB infection can drastically reduce TB-related illness, suggests a study by the Centers for Disease Control and Prevention... -
Gilead's Single-Tablet "Quad" Regimen For HIV Achieves A High Rate Of Virologic Suppression In Phase II Study
Posted: February 20th, 2010, 4:00am CST
Gilead Sciences, Inc... -
UBC Researcher Finds Improved Uptake Of Highly Active Antiretroviral Therapy
Posted: February 20th, 2010, 2:00am CST
A comprehensive population-based study, conducted by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and presented at the 17th Conference on Retroviruses and Opportunistic Infections in San Francisco, shows that expanded highly active antiretroviral therapy (HAART) coverage was associated with a 50% decrease in new yearly HIV infections among injection drug users... -
VIRxSYS Announces At CROI Promising Results From Its HIV Vaccine Study
Posted: February 19th, 2010, 5:00pm CST
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA... -
Program Provides Menstrual Kits To Reduce School Absenteeism In Kenya
Posted: February 19th, 2010, 7:00am CST
A U.S.-backed charity has begun distributing no-cost menstrual kits to Kenyan girls in an effort to address school absenteeism among low-income families, the New York Times reports... -
Phase II HIV Gene Therapy Trial Data At CROI 2010 Presented By Penn Researchers
Posted: February 19th, 2010, 7:00am CST
Researchers from the University of Pennsylvania School of Medicine presented the results from an ongoing Phase I/II open-label clinical trial of Lexgenleucel-T at the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA. Lexgenleucel-T is a cell and gene therapy product being investigated for the treatment of HIV infection... -
CDC Announces Leadership Posts In Global Health, Other Areas
Posted: February 19th, 2010, 6:00am CST
Centers for Disease Control and Prevention Director Thomas Frieden has named seven new members to the agency's management team, including experts on global health and HIV/AIDS, CQ HealthBeat reports. "Each member comes with hands-on experience in their respective field," Frieden said. The appointments include Kevin DeCock as the director of the Center for Global Health... -
HIV Prevention Strategies Often Overlook Long-Term Couples In Africa, Researchers Say
Posted: February 19th, 2010, 6:00am CST
Insufficient attention to HIV prevention among couples in long-term relationships contributes to the spread of the virus in sub-Saharan Africa, according to scientists presenting research at a recent conference, the Washington Post reports... -
State Policy Developments: Wisconsin's New 'Public Option,' Iowa's Medical Marijuana Vote, And More
Posted: February 19th, 2010, 6:00am CST
New Hampshire Public Radio: A bill in the state legislature would create an annual public report that details the causes of rising health spending by analyzing now-private information that doctors, hospitals and other health organizations would have to provide to the state's Department of Insurance... -
Also In Global Health News: HIV Prevention Strategies For Couples; Humanitarian Operations In Somalia; Gender Rights; Health Clinic In Uganda
Posted: February 19th, 2010, 6:00am CST
Studies Show Long-Term Couples Overlooked By HIV Prevention Strategies The Washington Post examines research presented at the 17th Conference on Retroviruses and Opportunistic Infections that indicates HIV prevention strategies in sub-Saharan Africa are overlooking the risk of transmission between couples in long-term relationships, fueling the spread of the disease... -
GeoVax Labs, Inc. Reports Data On Prototype Adjuvant - Supplemented HIV Vaccine Tested In Preclinical Animal Studies
Posted: February 19th, 2010, 4:00am CST
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus), announced that it presented the results of a preclinical study on a prototype HIV/AIDS vaccine at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco... -
Countries Urged To Review Progress Made In Achieving National AIDS Targets
Posted: February 19th, 2010, 3:00am CST
UNAIDS is calling for an international effort to renew commitment for countries to achieve universal access to HIV prevention, treatment, care and support... -
Study Integrating Family Planning And HIV Treatment & Care Funded By The Bill & Melinda Gates Foundation
Posted: February 19th, 2010, 2:00am CST
UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research... -
Human Health Benefits Predicted Following Sequencing Of Southern African Genomes
Posted: February 18th, 2010, 6:00am CST
Human genomes from Southern African Bushmen and Bantu individuals have been sequenced by a team of scientists seeking a greater understanding of human genetic variation and its effect on human health. The study's findings will be published in the journal Nature on 18 February 2010... -
Pharmacokinetic/Pharmacodynamic Data Support Further Development Of Tobira's Next-Generation CCR5 Receptor Antagonist
Posted: February 18th, 2010, 5:00am CST
Pharmacokinetic/pharmacodynamic (PK/PD) data for TBR-652, which is being developed by Tobira Therapeutics for the treatment of HIV infection, show a strong relationship between drug exposure and viral suppression with this next-generation CCR5 receptor antagonist. These data were presented here today at the 17th Conference on Retroviruses and Opportunistic Infections (CROI)... -
New Study Compares Efficacy And Safety Of Once-Daily Versus Twice-Daily PREZISTA(R) Regimen In Treatment-Experienced Adult Patients
Posted: February 18th, 2010, 4:00am CST
In a new study of treatment-experienced HIV-1-infected adults with no PREZISTA® (darunavir) resistance-associated mutations (RAMs), 72 percent of patients in the PREZISTA/ritonavir (r) (800/100 mg) once-daily arm achieved undetectable viral loads ( Once-daily PREZISTA/r is an investigational regimen for treatment-experienced adult patients... -
AHF/Magic Johnson HIV Testing Tour To Stop At Seven 'Historically Black Colleges'
Posted: February 17th, 2010, 9:00pm CST
AIDS Healthcare Foundation's 'Magic Johnson's Testing America' Tour, a 48-state national cross country HIV testing tour, is conducting an HIV testing tour through seven Historically Black Colleges in Louisiana, Alabama and Georgia throughout the month of February, to coincide with Black History Month and National Black HIV/AIDS Awareness Day (Feb.7)... -
Also In Global Health News: Boosting Banana Production; Measles Vaccines In Bangladesh; NTDs; Burkina Faso Maternal Care; Health Care, HIV In S.A.
Posted: February 17th, 2010, 6:00am CST
Moderate Fertilizer Use Could Double Banana Production In East Africa, Improve Food Security A study of almost 200 farms in Uganda, funded by USAID and carried out by the International Institute of Tropical Agriculture (IITA), found that moderate use of mineral fertilizers could double banana production in East Africa and improve the lives of more than 70 millio... -
AP Examines Male Circumcision Efforts In Africa, Including Adult Circumcision Devices
Posted: February 17th, 2010, 5:00am CST
The Associated Press examines efforts to prevent the spread of HIV by circumcising "about 50 million men across Africa - where 70 percent of the world's HIV-infected population lives... -
Award Winners Take Steps Toward Better Teaching Tools, Improved DNA Analysis And Maybe Even A Lower-Cost HIV Drug
Posted: February 16th, 2010, 5:00am CST
Three newly named beneficiaries of the Joshua E. Neimark Memorial Travel Assistance Endowment are investigating an unusual program to spark young children's interest in insects, an effort to fine-tune DNA analysis, and a strategy that might someday suggest a way to lower the cost of a key HIV medication... -
HIV-Associated Morbidity In Adolescents
Posted: February 16th, 2010, 2:00am CST
Nearly half of adolescents admitted to two public hospitals in Zimbabwe were HIV positive according to a new paper by Rashida Ferrand and colleagues which is published in this weeks PLoS Medicine... -
HIV Drug Resistance Lasts About One Year In Women Treated With Nevirapine To Prevent Infection Of Infants
Posted: February 16th, 2010, 2:00am CST
A new international study reported in PLoS Medicine confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission of the AIDS virus to their infants. However, the increased risk of failure could only be detected in women who began full HIV treatment within about a year after receiving sdNVP... -
Heat-Stable Ritonavir Approved: Years Of Medical Double Standards And Stranglehold By Abbott Come To An End
Posted: February 15th, 2010, 5:00am CST
Both the European Medicines Agency (EMEA) and the U.S. Food and Drug Administration have recently approved the long-awaited heat-stable 100mg tablet version of ritonavir, the antiretroviral booster drug produced by Abbott Laboratories... -
Treatment For Herpes Could Delay HIV Disease Progression In Patients Infected With Both Herpes And HIV
Posted: February 15th, 2010, 2:00am CST
An article published Online First and in an upcoming edition of The Lancet reports that recent research indicates that aciclovir, used to treat HSV2, could delay HIV-1 disease progression in patients co-infected with both conditions. In most cases, people who are infected with HIV-1 are dually infected with herpes simplex virus type 2 (HSV2)... -
Recent Releases In Global Health
Posted: February 15th, 2010, 2:00am CST
Lancet Comment Examines Interconnectedness Of Global Health, Public Health "Global health and public health are indistinguishable," according to a Lancet Comment that examines the interconnectedness of the fields... -
Terrence Higgins Trust Launches Course At 56 Dean Street, To Support Gay Men Recently Diagnosed With HIV, UK
Posted: February 14th, 2010, 2:00am CST
Terrence Higgins Trust (THT) is teaming up with Soho-based sexual health centre 56 Dean Street to launch a new workshop for gay men who have recently been diagnosed with HIV. The course, which launches on Tuesday 23 February, is free of charge and will run every Tuesday for six weeks... -
Abbott Receives U.S. FDA Approval For Heat-Stable Norvir(R) (ritonavir) Tablets
Posted: February 12th, 2010, 10:00am CST
Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir® (ritonavir). The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it more convenient for patients... -
Treating Herpes Does Not Reduce HIV Transmission, Study Finds
Posted: February 12th, 2010, 6:00am CST
Treating herpes in HIV-positive patients does not lower the risk that they will transmit HIV to their partners, despite the fact that herpes treatment has been shown to lower the level of HIV in the blood, according to a study published last week in the New England Journal of Medicine, the New York Times reports... -
Heavy Rains Hit Tent Camps In Haiti
Posted: February 12th, 2010, 6:00am CST
Heavy rains hit earthquake survivors in tent camps in Port-au-Prince on Thursday, "bringing a warning of fresh misery to come for the 1 million people living on the streets," Reuters reports... -
Also In Global Health News: China's Health Care System; Breastfeeding Practices In Pakistan; HIV Transmission In MSM; Abu Dhabi Joins Malaria Fight
Posted: February 12th, 2010, 6:00am CST
Los Angeles Times Examines China's Health Care Overhaul The Los Angeles Times examines China's transition to "Western-style privatized medicine" through the government's "$124-billion overhaul, chiefly to improve service in rural areas... -
PREZISTA(R) Now Approved As Part Of Combination Therapy For Pediatric Patients Six Years Of Age And Older With HIV
Posted: February 12th, 2010, 6:00am CST
Tibotec, a division of Janssen-Ortho Inc., announced that Health Canada has approved PREZISTA® (darunavir) for use in children with HIV between the ages of six and 18, dosed twice daily in combination with ritonavir and other antiretroviral agents. PREZISTA® is a protease inhibitor that works by blocking an enzyme critical for the growth of the virus within the body... -
Biomagnetics To Accelerate Availability Of The World's First Integrated Optical Biosensor For Malaria, Cholera, TB And HIV/AIDS Diagnosis
Posted: February 12th, 2010, 3:00am CST
Biomagnetics Diagnostics Corp. (Pink Sheets:BMGP), a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform... -
Builders Of Science Award
Posted: February 12th, 2010, 2:00am CST
Robert W. Mahley, MD, PhD, president of The J. David Gladstone Institutes, will receive Research!America's 2010 Builders of Science Award... -
Scientists Discover Origin Of HIV Transmission Among Male Partners
Posted: February 11th, 2010, 5:00am CST
A team of scientists, led by a virologist from the University of California, San Diego's Center for AID Research (CFAR), has discovered the origin of strains of human immunodeficiency virus (HIV) among men who have sex with men. The study, which may be important in developing prevention strategies for HIV, will appear in Science Translational Medicine on February 10, 2010... -
MAC AIDS Fund Survey Reveals 73 Percent Of Women Unaware Of Their Current HIV Status False Sense Of Security Prevents Most Women From Taking Control
Posted: February 11th, 2010, 4:00am CST
The MAC AIDS Fund (MAF) launched its latest VIVA GLAM campaign, a women's initiative aimed at strengthening the service network and resources available to women living with and at risk of contracting HIV. MAF commissioned nationwide surveys to gauge perceptions of HIV/AIDS and its impact on women through the lens of the American consumer and nation's leading experts... -
Burden Of HIV/TB Infections Falling On Hispanics
Posted: February 11th, 2010, 4:00am CST
The results of an innovative study to understand what factors may influence who contracts tuberculosis (TB)/HIV co-infection in San Diego show a significant shift in the ethnic makeup of the disease, with the majority of cases now coming from the Hispanic community... -
Researchers Reveal 3-D Structure Of Bullet-Shaped Virus With Potential To Fight Cancer, HIV
Posted: February 11th, 2010, 2:00am CST
Vesicular stomatitis virus, or VSV, has long been a model system for studying and understanding the life cycle of negative-strand RNA viruses, which include viruses that cause influenza, measles and rabies... -
CQ Examines Concerns Over Obama's FY2011 Global Health Budget
Posted: February 10th, 2010, 7:00am CST
Congressional Quarterly examines concerns among health advocates and international development experts about what President Obama's FY 2011 budget request might mean to U.S. commitments to particular diseases abroad, such as HIV/AIDS, tuberculosis and malaria... -
Also In Global Health News: Pakistan IDPs; HIV And Herpes; Ending FGM; WFP Budget In Afghanistan; Cholera In PNG
Posted: February 10th, 2010, 7:00am CST
U.N. Launches $538M Aid Appeal For Displaced Persons In Pakistan The U.N. launched an international appeal Tuesday, calling for $538 million to provide aid in Pakistan for "hundreds of thousands of people displace[d] by army clashes against the Taliban," the Associated Press/Washington Post reports (Toosi, 2/9)... -
GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For Therapeutic Vaccine To FDA
Posted: February 9th, 2010, 3:00am CST
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, provided an update on its vaccine trials progress... -
Quality Of Caregiver Relationship Is Crucial For HIV-Infected Children
Posted: February 8th, 2010, 4:00am CST
A new study of children in Ukraine has found that for the growing number of HIV-infected children, the quality of care and the relationship between children and their caregivers play an important role in their development... -
Recent Releases In Global Health
Posted: February 8th, 2010, 4:00am CST
Lancet Study Examines Childbirth Practices, Outcomes In Asian Countries A Lancet study examines childbirth practices and the relationship between these practices and maternal and perinatal outcomes in nine Asian countries, as assessed by a WHO global survey... -
Congressmen, Citing Reports Of Fraud, Seek Accounting For AIDS Funding
Posted: February 8th, 2010, 3:00am CST
"Two Republican congressmen who help oversee billions of dollars for people with AIDS are asking the federal government for an accounting of fraud and mismanagement complaints leveled against AIDS programs nationwide," The Washington Post reports. "Reps. Joe L. Barton (Tex.) and Greg Walden (Ore.) sent a letter Thursday to the U.S... -
$4.25 Million For HIV Research In Geneva
Posted: February 5th, 2010, 8:00am CST
The Mintaka Foundation for Medical Research in Geneva announced today that the Wellcome Trust, London, has awarded it approximately CHF 4,500,000 to meet the remaining costs of bringing its flagship product, an anti-HIV microbicide known as 5P12-RANTES, to a first safety trial in the clinic. Every year, there are millions of new infections from HIV... -
U.S. Lawmakers Introduce Resolution Condemning Uganda's Anti-Gay Bill
Posted: February 5th, 2010, 6:00am CST
U.S. lawmakers on Wednesday introduced a congressional resolution condemning an anti-gay bill before Uganda's parliament, "calling it an attack on human rights and an obstacle to battling HIV/AIDS," Agence France-Presse reports... -
Turning The Tide: 20 Years Of HIV/AIDS Research In Uganda
Posted: February 5th, 2010, 3:00am CST
On the twentieth anniversary of the Medical Research Council's (MRC) research unit's presence in Uganda, Director Heiner Grosskurth looks back on the changing landscape of research into HIV/AIDS at the commemorative scientific symposium in Entebbe today... -
Novel Therapies Could Improve Potency Of Existing AIDS Treatments, Help To Combat Drug-Resistant Virus Strains
Posted: February 5th, 2010, 2:00am CST
A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS... -
Also In Global Health News: GSK's Interest In NTDs; Kenya's Male Circumcision Drive; Dengue Fever; HIV Prevention In Jamaica; Food Shortages In Zimbab
Posted: February 4th, 2010, 7:00am CST
GSK Head Discusses Company Interest In NTDs The Associated Press features a Q&A with GlaxoSmithKline (GSK) CEO Andrew Witty, who "is pushing to sell more products in fast-growing 'emerging markets' such as Brazil, Russia, India and China" while simultaneously "increasing efforts to bring medicines for tropical diseases to the poorest countries, at minimum profit... -
New African Union Chair's Focus To Include Food Security; First Ladies Discuss HIV/AIDS
Posted: February 4th, 2010, 6:00am CST
The African Union (AU) Summit concluded in Addis Ababa, Ethiopia, on Tuesday with newly elected AU chairman Bingu Wa Mutharika, of Malawi, encouraging African leaders to make agriculture and food security a top priority, Angola Press reports (2/2). "Mr... -
NPR Examines Obama Administration's Global Family Planning Policies
Posted: February 4th, 2010, 6:00am CST
NPR's "Morning Edition" examines how global family planning fits into the Obama administration's global health policy. "The administration has already restored funding for the United Nations Population ... Fund, which for eight years received no U.S. support. And in his first week, President Obama lifted an executive order that existed in the Reagan and Bush administrations that prohibited U.S... -
Obama's FY 2011 Budget Gives Global Health Funding Boost
Posted: February 3rd, 2010, 7:00am CST
President Barack Obama's FY 2011 budget request for global health totals $9.6 billion and includes funding for global health activities within the State Department, USAID and HHS, the Wall Street Journal reports. "That compares with $8.8 billion enacted for fiscal 2010," according to the newspaper (McKay, 2/1)... -
Blogs Comment On Health Reform Prospects, Constitutionality Of Hyde Amendment, Other Topics
Posted: February 3rd, 2010, 6:00am CST
The following summarizes selected women's health-related blog entries. ~ "Dem Lawmaker: Strong Likelihood of Using Reconciliation To Pass Health Bill," Jordan Fabian, The Hill's "Blog Briefing Room": Rep. Eliot Engel (D-N.Y... -
New Vaccine Effective In Preventing TB In HIV-Positive Patients Phase III Trials Prove To Be A "Significant Milestone" In Vaccination Research
Posted: February 3rd, 2010, 4:00am CST
Results from clinical trials conducted in Tanzania show that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection... -
Two Studies Find Artefill(R) To Be A Long-Term Treatment Option For Facial Lipoatrophy
Posted: February 3rd, 2010, 4:00am CST
Suneva Medical, a privately-held aesthetic medical device company, announced that two clinical studies suggest Artefill may be a safe, effective, long-term treatment option for age-related and HIV lipoatrophy patients... -
Cell-Culture And Animal Tests Show Antiviral Could Provide Protection Against HIV, Ebola, Hepatitis C, Herpes And More
Posted: February 3rd, 2010, 2:00am CST
The development of antibiotics gave physicians seemingly miraculous weapons against infectious disease. Effective cures for terrible afflictions like pneumonia, syphilis and tuberculosis were suddenly at hand. Moreover, many of the drugs that made them possible were versatile enough to knock out a wide range of deadly bacterial threats... -
Secretary Sebelius Announces Members Of The Presidential Advisory Council On HIV/AIDS
Posted: February 2nd, 2010, 7:00pm CST
Health and Human Services Secretary Kathleen Sebelius announced today the appointment of 24 new members to the Presidential Advisory Council on HIV/AIDS (PACHA). The PACHA's chair, Dr. Helene Gayle, was appointed in August 2009... -
Early Intervention Important To Decrease STDs, HIV, Pregnancy
Posted: February 2nd, 2010, 7:00am CST
A new study weighs in on the controversy over sex education, finding that an abstinence-only intervention for pre-teens was more successful in delaying the onset of sexual activity than a health-promotion control intervention. After two years, one-third of the abstinence-only group reported having sex, compared to one-half of the control group... -
More Details On Obama's Global Health Strategy Expected Along With Budget Release, Wall Street Journal Reports
Posted: February 2nd, 2010, 6:00am CST
"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports... -
Experimental Vaccine Reduced TB Rate Among HIV-Positive People In Tanzania, Study Finds
Posted: February 2nd, 2010, 6:00am CST
An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports... -
Also In Global Health News: Retrovirus Enzyme; Audit Of USAID Program; Africa's Agriculture
Posted: February 2nd, 2010, 6:00am CST
Key Retrovirus Enzyme Grown In Lab A study published on Sunday in the journal Nature has shed light on the enzyme integrase, "which is found in retroviruses like HIV and is a target for some of the newest HIV medicines," Reuters reports... -
FDA Announces Safety Risk Associated With HIV Drug
Posted: February 2nd, 2010, 4:00am CST
The U.S. Food and Drug Administration announced on January 29 that non-cirrhotic portal hypertension, a rare, but serious, liver disorder, has been reported in some HIV patients taking Videx/Videx EC (didanosine). Videx is an antiretroviral medicine first approved by the FDA in 1991. Videx EC is a delayed-release version of Videx approved in 2000... -
Clinical Trial Proves New Vaccine Effective In Preventing TB In African Patients With HIV Infection
Posted: February 1st, 2010, 4:00am CST
Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection... -
After 20 Years Of Trying, HIV Researchers Solve Key Puzzle
Posted: February 1st, 2010, 4:00am CST
Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years, potentially leading to better treatments for HIV, in a study published in the journal Nature. The researchers, from Imperial College London and Harvard University, have grown a crystal that reveals the structure of an enzyme called integrase, which is found in retroviruses like HIV...